Results 11 to 20 of about 33,486 (230)

Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant P. aeruginosa

Emerging Microbes and Infections, 2023
Molecular carbapenem-resistance testing, such as for the presence of carbapenemases genes, is commonly implemented for the detection of carbapenemase-producing Enterobacterales. Carbapenemase-producing P.
Christian M Gill, Fred C Tenover, David P Nicolau   +2 more
exaly   +3 more sources

The Immaculate Carbapenemase Study [PDF]

Journal of Clinical Microbiology, 2017
ABSTRACT Carbapenemase-producing organisms, or CPOs, are Gram-negative pathogens that produce a transmissible carbapenemase and are typically resistant to most (sometimes all) antibiotics. We now face a global CPO pandemic of high mortality. In this issue of the Journal of Clinical Microbiology , Karlowsky
Kenneth S. Thomson
openaire   +3 more sources

An improved method for rapid detection and characterization of carbapenemase-producing Enterobacterales directly from positive blood cultures: dBLIMplus [PDF]

Microbiology Spectrum
In this study, a new phenotypic method “dBLIMplus” performed by using combination disks for both detection of carbapenemase activity and determination of the carbapenemase enzyme of carbapenemase-producing Enterobacterales strains from positive blood ...
Tugba Ayvalik Ruzgarkesen, Emel Sesli Cetin, Mumtaz Cem Sirin, Buket Aridogan   +3 more
doaj   +2 more sources

Detecting Carbapenemase Production amongst Gram Negative Isolates and its Role in Appropriate Antibiotic Selection

Journal of Pure and Applied Microbiology, 2020
Multidrug resistance has been increasing world wide amongst most microrganisms, and adding to increased rate of both hospital and community acquired infections. Of all resistance mechanisms the alarming spread of carbapenemase producers is most worrisome
Iva Chandola, Anamika Ojha, Dimple Raina, Nidhi Negi   +3 more
doaj   +2 more sources

The shift from “MIC-Only” back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know about updated CLSI guidance [PDF]

Journal of Clinical Microbiology
Carbapenem-resistant organisms (CROs) pose a major threat to global health due to limited therapeutic options and their capacity for rapid dissemination.
Patricia J. Simner
doaj   +2 more sources

Phenotypic and genotypic characterization of carbapenem resistant Klebsiella pneumoniae clinical isolates from Damietta, Egypt [PDF]

BMC Microbiology
Background The notable emergence of carbapenemase production is a critical problem threatening human health worldwide. Hence, this study aimed to monitor the prevalence of carbapenemase-producing Klebsiella pneumoniae in Damietta, Egypt.
Mohamed I. Abou-Dobara, Ahmed K. A. El-Sayed, Radwa N. Elmaghalawy, Hazem H. Saleh   +3 more
doaj   +2 more sources

Paradoxical carbapenemase activity detected by modified carbapenemase inactivation (mCIM) method in Citrobacter sedlakii

Journal of Clinical Microbiology
Screening for carbapenemase-producing Enterobacterales is a necessity for hospitals serving high-risk patient populations. Detection methods often incorporate the modified carbapenemase inactivation method (mCIM) test to verify carbapenemase production ...
D. Garrett Brown, Matthew Surette, Sreejana Ray, Kevin Guo, Reagan Chan, Liusheng Huang, Sanchita Das   +6 more
doaj   +3 more sources

Occurrence of ESBL, AmpC-ESBL, and Carbapenemase Producer Organisms in Clinical Specimens: An Observational Prospective Study

Journal of Pure and Applied Microbiology
Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae are the most common Gram-negative bacillus (GNB) isolates from clinical samples.
Rajal Dave, Abhijeet Joshi
doaj   +3 more sources

Can phenotypic methods accurately identify carbapenemase production in Morganellaceae?

Journal of Global Antimicrobial Resistance
AIM: We aimed to evaluate and compare the performance of two chromagenic media (CM) and the carbapenem-inactivation method (CIM) in identifying carbapenemase production in the Morganellaceae members.
Çisem Karaoğlu, Betül Ceyhuni, Zeynep Ceren Karahan, Iştar Dolapçı   +3 more
doaj   +2 more sources

Multicenter Analytical Performance Evaluation of the BD Phoenix NMIC-461 Panel for Carbapenemase Classification and Antimicrobial Susceptibility Testing of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp. [PDF]

Antibiotics
Objectives: To evaluate the capability of the BD Phoenix NMIC-461 panel in the detection and classification of carbapenemase production and antimicrobial susceptibility testing of 10 antimicrobial agents among Enterobacterales, Pseudomonas aeruginosa ...
Jingjia Zhang, Liying Sun, Ge Zhang, Wei Kang, Tong Wang, Jin Li, Haotian Gao, Qiwen Yang, Kuixia Sun, Qian Wang, Hongli Sun   +10 more
doaj   +2 more sources